- Country: USA
- Summary: Ambr 250 High Throughput Bioreactor System
- UST Ref No: 116114984
- Deadline: 27 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PANDHA25P0000-007301
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Synopses - Notice of Intent to Award Sole Source to Sartorius Stedim NA, Inc.
Date: Tuesday, 11 March 2025
Year: FY2025
Contracting Office Zip Code: 21702-9232
Contracting Office Address - USA Medical Research Acquisition Activity, 808 Schreider Street, Fort Detrick, MD 21702-5014
Subject: Notice of Intent to Sole Source Award
Ambr 250 High Throughput Bioreactor System for the Pilot Bioproduction Facility (PBF) at The Walter Reed Army Institute of Research (WRAIR)
The United State Army Medical Research Acquisition activity intends to negotiate on a sole source basis, IWA FAR 13.5, with Sartorius Stedim North America, Inc.
The Pilot Bioproduction Facility (PBF) at the Walter Reed Army Institute of Research (WRAIR) specializes in the development of vaccines and biologics for military-relevant infectious disease threats.
The purpose of this requirement is to have the PBF Manufacturing Science and Technology team to develop and maintain a Monoclonal Antibody (mAb) production capability for the development of biologics and therapeutics. A high throughput bioreactor is required for rapid development of scalable fermentation processes using multiple parallel bioreactors and a fully automated liquid handling platform, enabling researchers to test numerous conditions simultaneously, thereby accelerating the development process. This technology has been globally adopted for various bioprocess development and optimization applications.
Objectives:
This follow-on requirement is for a Brand Name or Equivalent of Ambr 250 High Throughput Bioreactor Systems and meets the Statement of Work and the Minimum Essential Characteristics (MECs). The period of performance will be one base year to include delivery, equipment, installation and one year support plus three option periods for support.
Support includes maintenance by OEM licensed and certified technicians.
THIS NOTICE OF INTENT IS NOT A REQU... - Documents:
SOW-Ambr-250-Bioreactor-system.pdf
MEC-Ambr-250-Bioreactor-system.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAmbr 250 High Throughput Bioreactor System - USA Tender
The DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA), a Government sector organization in USA, has announced a new tender for Ambr 250 High Throughput Bioreactor System. This tender is published on USARFP under UST Ref No: 116114984 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-27.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
